BioSerenity
VC Fund
Paris, France
BioSerenity is a VC fund in Paris focused on Health Care and Medical Device. BioSerenity souhaite aider la communauté scientifique à mieux comprendre l'épilepsie pour mieux la soigner. Une fois anonymisées et privées de tout lien avec le patient, les données recueillies seront mise à disposition des chercheurs de l'Institut du Cerveau et de la Moelle épinière (ICM). C'est un pas décisif pour faire avancer larecherche sur l'épilepsie et améliorer le futur du diagnostic
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries BioSerenity invests in
Stages BioSerenity invests in
Countries BioSerenity invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Jean-Eudes Le Douget
|
|||
Marie-Anne Bloch-Dumont
|
|||
Nicolas Jurado
|
|||
Pierre Frouin
|
|||
Samir Medjebar
|
Investment Focus
Industry
- Health Care 1 (100%)
- Medical Device 1 (100%)
- Health Diagnostics 1 (100%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Jean-Eudes Le Douget
Senior Data Scientist
|
Senior Data Scientist | Total investments: 0 | Find email | |
|
Marie-Anne Bloch-Dumont
Manager of Alliance
|
Manager of Alliance | Total investments: 0 | Find email | |
|
Nicolas Jurado
Director of Psychiatric Activity
|
Director of Psychiatric Activity | Total investments: 0 | Find email | |
|
Pierre Frouin
Founder & Chief Executive Officer
|
Founder & Chief Executive Officer | Total investments: 0 | Find email | |
|
Samir Medjebar
General Manager
|
General Manager | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
BOYDSense
|
BOYDSense specializes in developing non-invasive and affordable tools for measuring critical biomarkers via the exhaled breath. The company provides breath-based metabolomics focuses on the capture, identification, and quantification of volatile organic compound (VOC) biomarker patterns in human breath and using it to diagnose and monitor chronicdiseases.It was founded in 2015 and headquartered in South San Francisco, California. | $7.6M / Venture - Series Unknown / Apr 05, 2024 |
Co-Investors
Alpha MOS
1 deal together
Ambrosia Investments
1 deal together
European Innovation Council
1 deal together
European Innovation Council
1 deal together
Jolt Capital
1 deal together
Sweet Ventures
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does BioSerenity invest in?
BioSerenity invests primarily in Health Care, Medical Device and Health Diagnostics startups, most often at Venture - Series Unknown stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact BioSerenity?
Public channels for BioSerenity include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at BioSerenity?
The team at BioSerenity includes Jean-Eudes Le Douget (Senior Data Scientist), Marie-Anne Bloch-Dumont (Manager of Alliance) and Nicolas Jurado (Director of Psychiatric Activity). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
